UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictors of optimal virological response to potent antiretroviral therapy

AIDS (London), 1999-10, Vol.13 (14), p.1873-1880

1999

Volltextzugriff (PDF)

Polyglutamation of methotrexate: is methotrexate a prodrug?

The Journal of clinical investigation, 1985-09, Vol.76 (3), p.907-912

1985

Volltextzugriff (PDF)

The pharmacology and clinical use of methotrexate

The New England journal of medicine, 1983-11, Vol.309 (18), p.1094-1104

1983

Volltextzugriff (PDF)

Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder

Investigational new drugs, 1997-01, Vol.15 (2), p.157-163

1997

Volltextzugriff (PDF)

Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration

Journal of clinical oncology, 1991-03, Vol.9 (3), p.464-467

1991

Volltextzugriff (PDF)

Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma

American journal of clinical oncology, 1995-12, Vol.18 (6), p.488-490

1995

Volltextzugriff (PDF)

Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach

Annals of oncology, 1992-01, Vol.3 (1), p.79-81

1992

Volltextzugriff (PDF)

Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate

The Journal of clinical investigation, 1985-10, Vol.76 (4), p.1323-1329

1985

Volltextzugriff (PDF)

A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma

Investigational new drugs, 1994-01, Vol.12 (2), p.137-141

1994

Volltextzugriff (PDF)

Oral piritrexim : a phase II study in patients with advanced soft tissue sarcoma

Investigational new drugs, 1992-07, Vol.10 (2), p.97-98

1992

Volltextzugriff (PDF)

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

Cancer, 1992-02, Vol.69 (4), p.1008-1011

1992

Volltextzugriff (PDF)

Safety, pharmacokinetics, and pharmacodynamics results from a phase I trial of BAY 86-9766 (RDEA119), a MEK inhibitor, in patients with advanced cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3007-3007

2011

Volltextzugriff (PDF)

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer

Cancer, 1991-05, Vol.67 (9), p.2253-2257

1991

Volltextzugriff (PDF)

Potential Pitfalls in the Evaluation of the Usefulness of Hemodialysis for the Removal of Lithium

Clinical toxicology (Philadelphia, Pa.), 1982-01, Vol.19 (4), p.341-352

1982

Volltextzugriff (PDF)

Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three days

Investigational new drugs, 1992-11, Vol.10 (4), p.279-287

1992

Volltextzugriff (PDF)

Phase I evaluation of 773U82-HCI in a two-hour infusion repeated daily for three days

Investigational new drugs, 1992, Vol.10 (4), p.279-287

1992

Volltextzugriff (PDF)

Phase I trial of piritrexin capsules using prolonged, low-dose oral administration for the treatment of advanced malignancies

JNCI : Journal of the National Cancer Institute, 1991, Vol.83 (1), p.51-55

1991

Volltextzugriff (PDF)

A pilot study of piritrexim in mycosis fungoides

Archives of dermatology (1960), 1992-04, Vol.128 (4), p.561

1992

Volltextzugriff (PDF)

A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)-1 Protease, to Treat HIV Infection

The Journal of infectious diseases, 1998-06, Vol.177 (6), p.1533-1540

1998

Volltextzugriff (PDF)

Result of two randomized trials comparing nolatrexed (Thymitaq™) versus methotrexate in patients with recurrent head and neck cancer

Annals of oncology, 2001-11, Vol.12 (11), p.1595-1599

2001

Volltextzugriff (PDF)

Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1131-1141

1998

Volltextzugriff (PDF)

Safety, Pharmacokinetics, and Antiretroviral Activity of the Potent, Specific Human Immunodeficiency Virus Protease Inhibitor Nelfinavir: Results of a Phase I/II Trial and Extended Follow-up in Patients Infected with Human Immunodeficiency Virus

Journal of clinical pharmacology, 1998-08, Vol.38 (8), p.736-743

1998

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Biological And Medical Sciences
(17)
Life Sciences & Biomedicine
(17)
Medical Sciences
(17)
Pharmacology. Drug Treatments
(17)
Science & Technology
(17)
Female
(15)
Male
(15)
Antineoplastic Agents
(14)
Adult
(13)
Middle Aged
(13)
Aged
(12)
Chemotherapy
(11)
Oncology
(10)
Drug Administration Schedule
(7)
Drug Evaluation
(6)
Pyrimidines - Administration & Dosage
(6)
Administration, Oral
(5)
Head And Neck Neoplasms - Drug Therapy
(5)
Pyrimidines - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predictors of optimal virological response to potent antiretroviral therapy

Polyglutamation of methotrexate: is methotrexate a prodrug?

The pharmacology and clinical use of methotrexate

Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder

Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration

Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma

Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach

Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate

A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma

Oral piritrexim : a phase II study in patients with advanced soft tissue sarcoma

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

Safety, pharmacokinetics, and pharmacodynamics results from a phase I trial of BAY 86-9766 (RDEA119), a MEK inhibitor, in patients with advanced cancer

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer

Potential Pitfalls in the Evaluation of the Usefulness of Hemodialysis for the Removal of Lithium

Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three days

Phase I evaluation of 773U82-HCI in a two-hour infusion repeated daily for three days

Phase I trial of piritrexin capsules using prolonged, low-dose oral administration for the treatment of advanced malignancies

A pilot study of piritrexim in mycosis fungoides

A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)-1 Protease, to Treat HIV Infection

Result of two randomized trials comparing nolatrexed (Thymitaq™) versus methotrexate in patients with recurrent head and neck cancer

Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors

Safety, Pharmacokinetics, and Antiretroviral Activity of the Potent, Specific Human Immunodeficiency Virus Protease Inhibitor Nelfinavir: Results of a Phase I/II Trial and Extended Follow-up in Patients Infected with Human Immunodeficiency Virus

Aktive Filter

Suchergebnisse filtern